
    
      To evaluate the safety and effectiveness of the RX Herculink Elite Renal Stent System in the
      treatment of suboptimal post-procedural percutaneous transluminal angioplasty (PTA) of
      atherosclerotic de novo or restenotic renal artery stenosis in patients with uncontrolled
      hypertension.

      CAUTION: The Herculink Elite Renal Stent System Is An Investigational Device. Limited by
      Federal (U.S.) Law to Investigational Use Only.
    
  